Corrigendum: C-reactive protein isoforms as prognostic markers of COVID-19 severity
Blanca Molins, Marc Figueras-Roca, Oliver Valero, Victor Llorens, Sara Romero-Vázquez, Oriol Sibila, Alfredo Adan, Carolina Garcia-Vidal, Alex Soriano
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVitamin C and Antioxidants Research · COVID-19 Clinical Research Studies
In the published article, there was an error in the Funding statement. The first sentence was incorrectly written as “This work was funded by the Ministry of Science and Innovation of Spain, “Instituto de Salud Carlos III”, “Fondo de Investigación Sanitaria” (grant number PI19/00265), and Funds FEDER “Una manera de hacer Europa”. It should appear as “This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project PI19/00265 and co-funded by the European Union”. The correct Funding statement appears below.